MARY MACDONALD: Open Payments
NPI 1902990971 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,903 in 204 payments from 47 companies in 2025. Trend: 2023 $3,005 · 2024 $4,472 · 2025 $5,903
Food & beverage: $4,591Long term medical supply or device loan: $1,131Education: $181
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $1,441 |
| Merck Sharp & Dohme LLC | 16 | $425 |
| PFIZER INC. | 13 | $283 |
| E.R. Squibb & Sons, L.L.C. | 13 | $236 |
| Kite Pharma, Inc. | 4 | $200 |
| Janssen Biotech, Inc. | 9 | $192 |
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| Daiichi Sankyo Inc. | 7 | $172 |
| Celgene Corporation | 8 | $159 |
| Gilead Sciences, Inc. | 7 | $158 |
Products named: KISQALI, KEYTRUDA, Yescarta, OPDIVO, REBLOZYL, Trodelvy, IBRANCE, VERZENIO.
Industry payments across SC — which companies pay providers there.
